Fresenius Kabi Deutschland GmbH, part of Fresenius SE & Co. KGaA, is a company headquartered in Bad Homburg vor der Hohe, Germany, that manufactures drugs in pharmaceutical preparations for human and veterinary use. The firm was founded in 1999. Steffen Roser, Christoph Funke and Tanja Greve are the current co-CEOs of the company.

AXYS Pharmaceuticals, Inc. is engaged in discovery, design, and development of therapeutic small molecules that addressed significant markets with major unmet medical needs. It collaborates with large pharmaceutical companies in discovering therapeutics for chronic diseases. In addition, it also discovers and develops therapeutics for the treatment of various types of cancer and other specialty therapeutic opportunities. AXYS Pharmaceuticals, Inc. was formerly known as Arris Pharmaceuticals, Incorporated. The company is based in South San Francisco, California. As of November 16, 2001, AXYS Pharmaceuticals, Inc. operates as a subsidiary of Celera Corporation.

DNA Sciences, Inc., a subsidiary of AbbVie, Inc., is a company headquartered in Fremont, CA, that develops and produces in vitro diagnostic and research reagent products. It was founded by Hugh Young Rienhoff. DNA Sciences, Inc. was acquired by Genaissance Pharmaceuticals, Inc., now part of AbbVie, Inc. on April 01, 2003 for $1.30 million.

Randox Laboratories Ltd. provides clinical diagnostic solutions to laboratories. It develops, manufactures and markets high quality diagnostic reagents and equipment for laboratory medicine. The firm's products include Biochip Array Technology, clinical chemistry analyzers and reagents, quality control materials and schemes and an extensive life science portfolio. The company was founded by Peter FitzGerald in April 1982 and is headquartered in Crumlin, the United Kingdom.

Established in 1973 in Korea, Hanmi Pharmaceuticals now is one of the top 5 pharmaceutical companies in terms of revenue, and the most R&D focused company with the highest R&D investment for several years. Hanmi has been successful for a few decades with high flexibility, continuously changing its market/development strategy from first generics to IMD & FDC (Incrementally Modified Drug and Fixed Dose Combination) to new drug development including innovative small molecules and biologics. During the period of significant changes, Hanmi made multiple strategic collaboration relationships with multinational companies and biotech companies. Based on the success in 1980s and 1990s, Hanmi started its Chinese operation in 1996 with establishment of Beijing Hanmi. Now, Beijing Hanmi grew as a well-localized and well-settled Chinese company with more than 1,300 staffs including R&D, sales / marketing, and manufacturing experts and significant growth rate higher than 20% every year. Currently, Hanmi and Beijing Hanmi is closely collaborating on various business opportunities and new drug development projects as well as sales and marketing in Chinese territories. As the only Asian company with significant presence both in Korea and China, as the most R&D focused company with number of clinical stage projects with competitiveness, and as the company with open innovation based on multiple development/marketing collaborations, Hanmi is trying to develop and provide differentiated treatment options to patients suffering from various disease.

Genaissance Pharmaceuticals, Inc. develops and uses genetic information to diagnostic and therapeutic products. The company was founded by Kevin L. Rakin and Gualberto Ruano in 1992 and is headquartered in New Haven, CT.

Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium and owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and Development (J&J PRD), now renamed to Janssen Research and Development (JRD), which conducts research and development activities related to a wide range of human medical disorders, including mental illness, neurological disorders, anaesthesia and analgesia, gastrointestinal disorders, fungal infection, HIV/AIDS, allergies and cancer. Janssen and Ortho-McNeil Pharmaceutical have been placed in the Ortho-McNeil-Janssen group within Johnson & Johnson Company.

Beijing Clairix Controlled-Release Pharmaceutical Co., Ltd., established on 1994-04-15, The scope of business includes the production of pharmaceuticals;sell food;retail medicine;Sales of Class III Medical Devices;Chinese and Western medicine preparations,sanitary material,Technology development of chemical products,technology transfer,Technical Services,technical consulting;Sales of transdermal controlled-release patch equipment,Chemical Products(Free of Hazardous Chemicals),hygiene products,Daily Disinfectant,cosmetic,medical instruments(Ι,Class II);Operate the self-produced products and technology export business of the enterprise and its member enterprises;Raw and auxiliary materials required for the production of the enterprise and member enterprises,Instrumentation,Equipment,Import and export business of spare parts and technology(The state restricts the operation of the company and the state prohibits the import and export of goods except);operating incoming material processing and"Three to one make up"business.(Market entities independently choose business projects in accordance with the law,Carry out business activities;production of medicines,sell food,retail medicine,Sales of Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

Meiji Seika Pharma Co., Ltd. engages in the business of manufacture and distribution of pharmaceutical products. It also engages in the animal health business. The company was founded on October 9, 1916 and is headquartered in Tokyo, Japan.

Medimop Medical Projects Ltd., part of West Pharmaceutical Services, Inc., is a company headquartered in Raanana, Israel, that develops medical devices used as pharmaceutical connectors. The firm was acquired by West Pharmaceutical Services, Inc. on July 05, 2005 for $41.80 million.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN.

Zeria Pharmaceutical produces veterinary pharmaceuticals, agricultural chemicals, industrial chemicals and reagents, and more. In addition, they also provide cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, and more.

Part of West Pharmaceutical Services, Inc., West Pharma. Services IL Ltd. is a company headquartered in Israel that manufactures containment and delivery systems for injectable medicines.

Part of Precipio, Inc., PGxHealth LLC is an American company located in New Haven, CT. The firm engages in clinical laboratory testing services.

Guangxi Jiufu Biotechnology Co., Ltd., established on 2015-12-11, Business scope includes technology development of biotechnology,technology R & D,Technical Services,technical consulting,technology transfer;Sales of native Chinese herbal medicines.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Abbott Healthcare Products BV, part of Abbott Laboratories, is a company headquartered in Weesp, the Netherlands, that manufactures and distributes pharmaceuticals.